Actively Recruiting
Care Coordination and Communication Program in Oncology for Tribal Health Systems (C3PO)
Led by University of Oklahoma · Updated on 2026-03-25
187
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
U
University of Oklahoma
Lead Sponsor
N
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a new program designed to improve navigation assistance specifically for Native American cancer patients. This program, called the Care Coordination and Communication Program in Oncology for Tribal Health Systems (C3PO), seeks to address communication barriers by fostering collaboration between the Stephenson Cancer Center and tribally operated healthcare systems. The goal is to provide culturally sensitive and coordinated care to improve patient outcomes. The study includes two phases. Phase I is a 3-month open pilot enrolling up to 15 patients who will receive the C3PO intervention, including navigation services and collaborative care meetings that discuss treatment side effects, comorbidities, and barriers like transportation or financial hardship. Phase II is a randomized controlled trial where patients are assigned either to continue usual navigation services or to receive the C3PO intervention with additional collaborative care meetings. After six months, those initially receiving usual care will also gain access to the C3PO program. Participants will complete baseline assessments, monthly surveys, and exit interviews during the pilot phase. Throughout the study, researchers will monitor and assess patient-reported outcomes such as perceptions of care coordination needs, number of missed visits, and time from diagnosis to initial treatment. The study emphasizes ongoing communication and support, with virtual or in-person meetings available to address patient needs. The total participation duration varies by phase, with follow-up extending up to three years for some outcome measures.
CONDITIONS
Brief Title
Program in Oncology for Tribal Health Systems.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be at least 18 years old
- Participants must be within eight weeks of a newly diagnosed cancer confirmed by pathology or imaging
- Participants must be navigated through the Native American Navigation Program at the Stephenson Cancer Center
- Participants must have verbal fluency in English
You will not qualify if you...
- Participants in the Phase 1 open pilot are not eligible for Phase 2 randomized controlled trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Duration - 3 months
Participants complete baseline assessments and participate in the C3PO intervention, including monthly collaborative care meetings and exit interviews at study conclusion.
Monthly visits for assessments and collaborative care meetings
Duration - 6 months
Participants assigned to the C3PO intervention receive navigation services along with collaborative care meetings discussing their clinical care and social needs.
Monthly collaborative care meetings without patient presence
Duration - 6 months
Participants receive standard Native American navigation services without collaborative care meetings during the initial 6 months.
Routine navigation service visits as scheduled
Duration - Up to 18 months
Participants initially assigned to usual care become eligible to receive the C3PO intervention after 6 months, including collaborative care meetings and navigation services.
Monthly collaborative care meetings and navigation visits
Duration - Up to 3 years
Participants continue to be observed for study outcomes such as cancer care coordination needs, missed visits, and treatment timelines.
Periodic assessments as scheduled
Trial Site Locations
Total: 1 location
1
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, United States, 73117
Actively Recruiting
Research Team
A
Amanda Janitz, Ph.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here